| Metric | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Total liabilities and stockholders' equity | $29.3B | $29.6B | $28.3B | $28.9B | $29.5B | $30.7B | $30.5B | $30.7B |
| Retained earnings | $19.1B | $19.6B | $20.3B | $21.1B | $21.8B | $22.4B | $23.0B | $23.6B |
| Total stockholders' equity | $12.1B | $12.9B | $13.1B | $13.4B | $13.7B | $13.8B | $14.3B | $14.6B |
| Treasury stock | $6.0B | $6.0B | $6.0B | $6.7B | $7.5B | $8.6B | $8.7B | $9.0B |
| Accumulated other comprehensive income (loss) | -$1.4B | -$1.1B | -$1.5B | -$1.4B | -$883.0M | -$924.0M | -$903.0M | -$980.0M |
| Additional paid-in capital | $264.0M | $275.0M | $244.2M | $243.7M | $194.0M | $823.0M | $822.0M | $824.0M |
| Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | $91.0M | $90.5M | $90.5M | $90.5M | $91.0M | $91.0M | $91.0M | $91.0M |
| Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| Share-Based Payment - Unrecognized Cost of Nonvested Awards | — | — | — | — | $142.0M | — | — | — |
| Undistributed Earnings of Foreign Subsidiaries | $1.1B | — | — | — | $1.0B | — | — | — |